Quick Answer
Hinge Health, Inc. reported Diluted EPS of $7.77 per share (loss) for fiscal year 2025.
Hinge Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$7.77 | -783.0% |
| 2024 | -$0.88 | +89.4% |
| 2023 | -$8.31 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | -300.0% | +99.8% |
| June 30, 2025 | -$13.10 | -1264.6% | -131100.0% |
| September 30, 2024 | $0.01 | — | +101.0% |
| June 30, 2024 | -$0.96 | — | — |
- Hinge Health, Inc. showed a decrease of -783.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Hinge Health, Inc.’s diluted eps has grown by 6.5% (from $8.31 per share (loss) to $7.77 per share (loss)).
- The most recent figure is from Hinge Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: